|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/24 | (2006.01) |
| A61K 39/00 | (2006.01) |
| (11) | Number of the document | 2842968 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14184563.6 |
| Date of filing the European patent application | 2006-04-28 | |
| (97) | Date of publication of the European application | 2015-03-04 |
| (45) | Date of publication and mention of the grant of the patent | 2018-05-23 |
| (46) | Date of publication of the claims translation | 2018-09-25 |
| (30) | Number | Date | Country code |
| 676498 P | 2005-04-29 | US | |
| 677319 P | 2005-05-03 | US |
| (72) |
Chen, Yan, US
Gardner, Debra, US
Knight, David, M., US
Lark, Michael, W., US
Liang, Bailin, US
Shealy, David, J., US
Song, Xiao-Yu, R., US
Stojanovic-Susulic, Vedrana, US
Sweet, Raymond, W, US
Tam, Susan, H., US
Wu, Sheng-Jiun, US
Yang, Jing, US
Marquis, David, Matthew, US
Smith, Eric, Michael, US
Vasserot, Alain, Philippe, US
|
| (73) |
ELI LILLY AND COMPANY,
Lilly Corporate Center, Indianapolis, IN 46285,
US
Janssen Biotech, Inc., 800/850 Ridgeview Drive, Horsham, PA 19044, US |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Humanizuoti anti-IL-6 antikūnai, kompozicijos, būdai ir panaudojimas |
| Humanized anti-IL-6 antibodies, compositions, methods and uses |
| Payment date | Validity (years) | Amount | |
| 2025-03-21 | 20 | 347.00 EUR |